1. Home
  2. LXRX vs ISD Comparison

LXRX vs ISD Comparison

Compare LXRX & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ISD
  • Stock Information
  • Founded
  • LXRX 1995
  • ISD 2012
  • Country
  • LXRX United States
  • ISD United States
  • Employees
  • LXRX N/A
  • ISD N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ISD Trusts Except Educational Religious and Charitable
  • Sector
  • LXRX Health Care
  • ISD Finance
  • Exchange
  • LXRX Nasdaq
  • ISD Nasdaq
  • Market Cap
  • LXRX 428.8M
  • ISD 472.3M
  • IPO Year
  • LXRX 2000
  • ISD N/A
  • Fundamental
  • Price
  • LXRX $1.19
  • ISD $14.50
  • Analyst Decision
  • LXRX Buy
  • ISD
  • Analyst Count
  • LXRX 5
  • ISD 0
  • Target Price
  • LXRX $3.23
  • ISD N/A
  • AVG Volume (30 Days)
  • LXRX 2.4M
  • ISD 127.1K
  • Earning Date
  • LXRX 08-06-2025
  • ISD 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • ISD 9.69%
  • EPS Growth
  • LXRX N/A
  • ISD N/A
  • EPS
  • LXRX N/A
  • ISD N/A
  • Revenue
  • LXRX $58,432,000.00
  • ISD N/A
  • Revenue This Year
  • LXRX N/A
  • ISD N/A
  • Revenue Next Year
  • LXRX N/A
  • ISD N/A
  • P/E Ratio
  • LXRX N/A
  • ISD N/A
  • Revenue Growth
  • LXRX 1504.83
  • ISD N/A
  • 52 Week Low
  • LXRX $0.28
  • ISD $10.98
  • 52 Week High
  • LXRX $2.18
  • ISD $13.17
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 56.85
  • ISD 61.15
  • Support Level
  • LXRX $1.12
  • ISD $14.35
  • Resistance Level
  • LXRX $1.27
  • ISD $14.48
  • Average True Range (ATR)
  • LXRX 0.09
  • ISD 0.09
  • MACD
  • LXRX -0.00
  • ISD -0.02
  • Stochastic Oscillator
  • LXRX 68.00
  • ISD 64.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About ISD PGIM High Yield Bond Fund Inc.

PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.

Share on Social Networks: